Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells

A panning method has been developed to enrich Langerhans cells (LC) from murine epidermis. In standard culture media, the enriched populations progressively lose viability over a 3-d interval. When the cultures are supplemented with keratinocyte-conditioned medium, LC viability is improved and the cells increase in size and number of dendritic processes. Accessory function, as monitored by stimulating activity in the mixed lymphocyte reaction (MLR), increases at least 10- 20-fold. The conditioned media of stimulated macrophages and T cells also support the viability and maturation of cultured LC. A panel of purified cytokines has been tested, and only granulocyte/macrophage colony-stimulating factor (GM-CSF) substitutes for bulk-conditioned medium. The recombinant molecule exhibits half-maximal activity at 5 pM. Without activity are: IL-1-4; IFN-alpha/beta/gamma; cachectin/TNF; M- and G-CSF. A rabbit anti-GM-CSF specifically neutralizes the capacity of keratinocyte-conditioned medium to generate active LC. However, GM-CSF is not required for LC function during the MLR itself. We conclude that the development of immunologically active LC in culture is mediated by GM-CSF. The observation that these dendritic cells do not respond to lineage-specific G- and M-CSFs suggests that LC represent a distinct myeloid differentiation pathway. Because GM-CSF can be made by nonimmune cells and can mediate the production of active dendritic cells, this cytokine provides a T-independent mechanism for enhancing the sensitization phase of cell-mediated immunity.

[1]  R. Steinman,et al.  Quantitation of surface antigens on cultured murine epidermal Langerhans cells: rapid and selective increase in the level of surface MHC products. , 1988, The Journal of investigative dermatology.

[2]  R. Steinman,et al.  Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells , 1987, The Journal of experimental medicine.

[3]  L. Park,et al.  Development and characterization of antiserum to murine granulocyte-macrophage colony-stimulating factor. , 1986, Journal of immunology.

[4]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. , 1986, Science.

[5]  R. Coffman,et al.  Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Metcalf Granulocyte-macrophage colony-stimulating factors , 1985, Cell.

[7]  R. Steinman,et al.  A comparison of murine epidermal Langerhans cells with spleen dendritic cells. , 1985, The Journal of investigative dermatology.

[8]  R. Steinman,et al.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro , 1985, The Journal of experimental medicine.

[9]  R. Steinman,et al.  Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release , 1984, The Journal of experimental medicine.

[10]  M. Vadas,et al.  Hemopoietic colony-stimulating factors. , 1984, Immunology today.

[11]  K. Arai,et al.  Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Lomedico,et al.  Cloning and expression of murine interleukin-1 cDNA in Escherichia coli , 1984, Nature.

[13]  C. Pugh,et al.  Characterization of nonlymphoid cells derived from rat peripheral lymph , 1983, The Journal of experimental medicine.

[14]  P. Steeg,et al.  Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity , 1982, The Journal of experimental medicine.

[15]  J. Ihle,et al.  Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line. , 1982, Journal of immunology.

[16]  P. Tynan,et al.  Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy , 1982, Cell.

[17]  Z. Cohn,et al.  Studies of the cell surface of mouse dendritic cells and other leukocytes , 1981, The Journal of experimental medicine.

[18]  R. Steinman,et al.  Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages , 1980, The Journal of experimental medicine.

[19]  T. Springer Cell-Surface Differentiation in the Mouse , 1980 .

[20]  R. Steinman,et al.  Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro , 1979, The Journal of experimental medicine.

[21]  L. Wysocki,et al.  "Panning" for lymphocytes: a method for cell selection. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Steinman,et al.  IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE , 1973, The Journal of experimental medicine.

[23]  L. Old,et al.  SEROLOGICALLY DEMONSTRABLE ALLOANTIGENS OF MOUSE EPIDERMAL CELLS , 1972, The Journal of experimental medicine.